Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis
Tor Olofsson, Jonas K Söderling, Anders Gülfe, Lars-Erik Kristensen, Johan K Wallman
Dyk ned i forskningsemnerne om 'Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis'. Sammen danner de et unikt fingeraftryk.